Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-beach symbols : FNCTF save search
Biological Dynamics Announces Expanding Adoption of ExoVerita™ Pro Under Early Access Program
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -100.0%
H: NaN%
C: Infinity%
pro program
City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial
Published: 2024-03-07 (Crawled : 12:30) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 0.79%
H: 0.78%
C: 0.78%
MBIO | $0.373 7.74% 7.18% 440K
|
Health Technology
|
| O: 8.33%
H: 4.2%
C: -2.8%
FBIO | $1.79 1.7% 1.68% 240K
|
Health Technology
|
| O: 2.93%
H: 0.0%
C: -9.21%
tumors cell city trial therapy
Harvard Eye Associates Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma
Published: 2024-02-20 (Crawled : 20:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
glaucoma ocular offering treatment hypertension eye
Astiva Health Files Statement for Proposed Initial Public Offering
Published: 2023-12-15 (Crawled : 21:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
health offering
City of Hope Scientists Present Promising New Research at American Society of Hematology Annual Meeting
Published: 2023-12-11 (Crawled : 20:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
hope city research meeting
NEURELIS SECURES NEW ORANGE BOOK LISTED U.S. PATENT FOR VALTOCO® (DIAZEPAM NASAL SPRAY) CIV
Published: 2023-11-27 (Crawled : 19:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
valtoco patent
Vibrato Medical Announces Positive Results for Early Feasibility Study of Wearable, Non-Invasive Therapeutic Ultrasound to Treat Chronic Limb-Threatening Ischemia (CLTI)
Published: 2023-11-01 (Crawled : 21:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -1.44%
H: 0.0%
C: -1.88%
positive treat medical results study
City of Hope Opens First U.S. Multicenter Clinical Trial for Robotic Single-Port Mastectomies for Breast Cancer Patients
Published: 2023-10-03 (Crawled : 16:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
breast hope cancer city trial
Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire
Published: 2023-09-27 (Crawled : 14:30) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -2.28%
H: 0.0%
C: 0.0%
phexxi fda approval market
New Multicenter Study Reveals Neurological Pupil index™ (NPi) as Predictor of Outcome and Mortality in Brain Injury Patients
Published: 2023-09-07 (Crawled : 17:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 5.1%
H: 0.0%
C: 0.0%
predictor neurological study
City of Hope diabetes experts present new research on beta cells, insulin secretion and islet transplantation at annual American Diabetes Association (ADA) Conference
Published: 2023-06-27 (Crawled : 14:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
conference association hope city research diabetes insulin
New study finds continuing immunotherapy once cancer progresses doesn't work and could cause harm
Published: 2023-06-06 (Crawled : 19:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
work cancer immunotherapy study
United States Patent and Trademark Office (USPTO) Grants Evoke Pharma a Formulation Patent Covering GIMOTIThe Company Will Submit for FDA Orange-Book Listing in the Near Term
Published: 2023-04-20 (Crawled : 14:20) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -0.47%
H: 0.0%
C: 0.0%
EVOK | News | $0.549 16.81% 14.39% 19K
|
Health Technology
|
| O: 15.24%
H: 0.0%
C: -11.57%
fda pharma patent grants
Primmune Therapeutics Presents New Clinical Data from Phase 1 Study Evaluating PRTX007 in Healthy Volunteers at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Published: 2023-04-18 (Crawled : 14:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
prtx007 association cancer research meeting therapeutics study
City of Hope scientists present potential new treatments for chronic lymphocytic leukemia, myelofibrosis and other diseases at American Association of Cancer Research (AACR) Annual Meeting
Published: 2023-04-17 (Crawled : 16:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
association hope cancer city research meeting potential
aTyr Pharma Presents Preclinical Research Demonstrating Treatment with ATYR2810 Inhibits Tumor Growth and Therapy Resistance in Highly Aggressive Cancers at the 2023 AACR Annual Meeting
Published: 2023-04-17 (Crawled : 14:00) - biospace.com/
LIFE | $1.59 -1.24% -1.26% 540K
|
Health Technology
|
| O: 1.05%
H: 1.04%
C: -0.52%
atyr2810 pharma treatment tumor research preclinical meeting therapy growth
City of Hope appoints John D. Carpten, Ph.D., as director of its comprehensive cancer center and Beckman Research Institute, and chief scientific officer
Published: 2023-04-06 (Crawled : 19:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -0.36%
H: 0.0%
C: 0.0%
hope cancer city research
Primmune Therapeutics to Present New Clinical Data from Phase 1 Study Evaluating PRTX007 at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Published: 2023-03-14 (Crawled : 00:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
prtx007 research meeting association therapeutics cancer study phase 1
Onchilles Pharma Announces Presentation of Preclinical Data for N17350 at AACR 2023
Published: 2023-03-14 (Crawled : 00:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
pharma preclinical presentation
Alignment Healthcare to Announce Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call Tuesday, Feb. 28, 2023
Published: 2023-01-31 (Crawled : 16:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 0.68%
H: 0.0%
C: 0.0%
ALHC | $4.945 0.92% 0.91% 780K
|
|
| O: 0.17%
H: 4.54%
C: 3.87%
conference financial results
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.